Exact Sciences (EXAS) Gross Profit (2010 - 2025)

Exact Sciences (EXAS) has 16 years of Gross Profit data on file, last reported at $615.8 million in Q4 2025.

• Gross Profit for Q4 2025 came in at $615.8 million, up 25.02% year-over-year; the trailing twelve-month figure through Dec 2025 was $2.3 billion (up 17.93% YoY), and the FY2025 annual result was $2.3 billion, up 17.93% from the prior year.
• Gross Profit rose to $615.8 million in Q4 2025 per EXAS's latest filing, from $583.9 million in the prior quarter.
• Over five years, Gross Profit peaked at $615.8 million in Q4 2025 and troughed at $271.5 million in Q1 2021.
• A 5-year average of $430.6 million and a median of $441.7 million in 2023 frame the typical range for Gross Profit.
• The sharpest annual moves came in 2021 and 2022: Gross Profit jumped 75.84% in 2021, then retreated 10.11% in 2022.
• A 5-year view of Gross Profit shows it stood at $354.8 million in 2021, then declined by 10.11% to $318.9 million in 2022, then soared by 42.35% to $453.9 million in 2023, then climbed by 8.52% to $492.6 million in 2024, then increased by 25.02% to $615.8 million in 2025.
• Business Quant data shows EXAS's Gross Profit at $615.8 million in Q4 2025, $583.9 million in Q3 2025, and $562.5 million in Q2 2025.